• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NASDAQ:CADL

Recent news which mentions NASDAQ:CADL

Investing in Oncology: 4 Companies Driving Cancer Treatment Innovation
April 09, 2025
Tickers CADL DAWN YMAB
Tags NASDAQ:DAWN NYSE:OSTX NASDAQ:CADL
From News Direct
CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024
August 13, 2024
Tickers CADL
Tags Market News Earnings Reports NASDAQ:CADL
From InvestorPlace
Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments
June 14, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics’ (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers
June 07, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
June 03, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
CADL Stock Earnings: Candel Therapeutics Reported Results for Q1 2024
May 14, 2024
Tickers CADL
Tags Earnings Reports NASDAQ:CADL CADL
From InvestorPlace
CADL Stock Earnings: Candel Therapeutics Misses EPS for Q4 2023
March 28, 2024
Tickers CADL
Tags NASDAQ:CADL CADL Earnings Reports
From InvestorPlace
Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors
March 15, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Moving Fast: Candel’s (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer
February 28, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
Candel Therapeutics Sets Stage For Success With Cancer-Fighting Immunotherapies
February 15, 2024
Tickers CADL
Tags NASDAQ:CADL
From News Direct
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap